Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constance Thibault

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Critical Reviews in Oncology/Hematology|April 10, 2013
HER2 status for prognosis and prediction of treatment efficacy in adenocarcinomas: a reviewConstance Thibault, Wassim Khodari, Marie Lequoy, et al.
The Oncologist|August 29, 2022
Regarding "Management of Dermatologic Events Associated with the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin"Saskia Ingen-Housz-Oro, Constance Thibault, Pierre Sohier, et al.
La Revue Du Praticien|March 15, 2019
[Treatment of metastatic prostate cancer: what recent progress?]Stéphane Oudard, Maud Velev, Yassine Belhadj, et al.
European Urology Focus|July 3, 2024
Radiation Therapy for Locally Advanced Prostate Cancer: How Do We Treat Patients with cN1 Disease?Jean-Emmanuel Bibault, Méjean Arnaud, Fabien Hyafil, et al.
Cancers|June 28, 2023
Innovation in Radionuclide Therapy for the Treatment of Prostate Cancers: Radiochemical Perspective and Recent Therapeutic PracticesEmmanuel Deshayes, Cyril Fersing, Constance Thibault, et al.
Oncoimmunology|July 9, 2015
Trial Watch: Therapeutic vaccines in metastatic renal cell carcinomaPierre Combe, Eleonore de Guillebon, Constance Thibault, et al.
European Journal of Cancer Care|December 19, 2020
Pharmaceutical consultation to detect drug interactions in patients treated with oral chemotherapies: A descriptive cross-sectional studyCélia Lachuer, Germain Perrin, Aymeric Chastel, et al.
The French Journal of Urology|September 19, 2024
Real-world evaluation of nivolumab utilization in adjuvant treatment of localized muscle-invasive urothelial carcinomaAymeric Guilbert, Thierry Lebret, Stephane Oudard, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
Imaging Response of Antiangiogenic and Immune-Oncology Drugs in Metastatic Renal Cell Carcinoma (mRCC): Current Status and Future ChallengesLaure Fournier, Alexandre Bellucci, Yann Vano, et al.
Bulletin Du Cancer|June 27, 2022
Future treatment options in metastatic clear cell renal cell carcinomaAudrey Simonaggio, Marie Auvray-Kuentz, Adrien Rochand, et al.
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Critical Reviews in Oncology/Hematology|April 10, 2013
HER2 status for prognosis and prediction of treatment efficacy in adenocarcinomas: a reviewConstance Thibault, Wassim Khodari, Marie Lequoy, et al.
The Oncologist|August 29, 2022
Regarding "Management of Dermatologic Events Associated with the Nectin-4-directed Antibody-Drug Conjugate Enfortumab Vedotin"Saskia Ingen-Housz-Oro, Constance Thibault, Pierre Sohier, et al.
La Revue Du Praticien|March 15, 2019
[Treatment of metastatic prostate cancer: what recent progress?]Stéphane Oudard, Maud Velev, Yassine Belhadj, et al.
European Urology Focus|July 3, 2024
Radiation Therapy for Locally Advanced Prostate Cancer: How Do We Treat Patients with cN1 Disease?Jean-Emmanuel Bibault, Méjean Arnaud, Fabien Hyafil, et al.
Cancers|June 28, 2023
Innovation in Radionuclide Therapy for the Treatment of Prostate Cancers: Radiochemical Perspective and Recent Therapeutic PracticesEmmanuel Deshayes, Cyril Fersing, Constance Thibault, et al.
Oncoimmunology|July 9, 2015
Trial Watch: Therapeutic vaccines in metastatic renal cell carcinomaPierre Combe, Eleonore de Guillebon, Constance Thibault, et al.
European Journal of Cancer Care|December 19, 2020
Pharmaceutical consultation to detect drug interactions in patients treated with oral chemotherapies: A descriptive cross-sectional studyCélia Lachuer, Germain Perrin, Aymeric Chastel, et al.
The French Journal of Urology|September 19, 2024
Real-world evaluation of nivolumab utilization in adjuvant treatment of localized muscle-invasive urothelial carcinomaAymeric Guilbert, Thierry Lebret, Stephane Oudard, et al.
Kidney Cancer (Clifton, Va.)|October 19, 2018
Imaging Response of Antiangiogenic and Immune-Oncology Drugs in Metastatic Renal Cell Carcinoma (mRCC): Current Status and Future ChallengesLaure Fournier, Alexandre Bellucci, Yann Vano, et al.
Bulletin Du Cancer|June 27, 2022
Future treatment options in metastatic clear cell renal cell carcinomaAudrey Simonaggio, Marie Auvray-Kuentz, Adrien Rochand, et al.
Pageof 11